Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled study of oral cromolyn sodium when
made into a viscous preparation for the treatment of eosinophilic esophagitis.